195 related articles for article (PubMed ID: 36639629)
21. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model.
Kuriakose MA; Chen FA; Egilmez NK; Jong YS; Mathiowitz E; DeLacure MD; Hicks WL; Loree TL; Bankert RB
Head Neck; 2000 Jan; 22(1):57-63. PubMed ID: 10585606
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas.
Doescher J; Piontek G; Wirth M; Bettstetter M; Schlegel J; Haller B; Brockhoff G; Reiter R; Pickhard A
Oral Oncol; 2015 Oct; 51(10):929-34. PubMed ID: 26272275
[TBL] [Abstract][Full Text] [Related]
24. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
[TBL] [Abstract][Full Text] [Related]
25. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.
Jiang R; Ekshyyan O; Moore-Medlin T; Rong X; Nathan S; Gu X; Abreo F; Rosenthal EL; Shi M; Guidry JT; Scott RS; Hutt-Fletcher LM; Nathan CA
J Oral Pathol Med; 2015 Jan; 44(1):28-36. PubMed ID: 25040496
[TBL] [Abstract][Full Text] [Related]
26. [Advances in risk factors and genetic risk of head and neck squamous cell carcinoma].
Tu X; Ren J; Zhao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 May; 36(5):391-396. PubMed ID: 35483694
[No Abstract] [Full Text] [Related]
27. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
28. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE
Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613
[TBL] [Abstract][Full Text] [Related]
29. Association of Human Papillomavirus and Epstein-Barr Virus Infection with Tonsil Cancer in Northeastern Thailand.
Heawchaiyaphum C; Ekalaksananan T; Patarapadungkit N; Vatanasapt P; Pientong C
Asian Pac J Cancer Prev; 2022 Mar; 23(3):781-787. PubMed ID: 35345347
[TBL] [Abstract][Full Text] [Related]
30. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype.
Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ
Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937
[TBL] [Abstract][Full Text] [Related]
31. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
32. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
[TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
34. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
[TBL] [Abstract][Full Text] [Related]
35. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.
Islas-Ohlmayer M; Padgett-Thomas A; Domiati-Saad R; Melkus MW; Cravens PD; Martin Mdel P; Netto G; Garcia JV
J Virol; 2004 Dec; 78(24):13891-900. PubMed ID: 15564497
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1.
Liebertz DJ; Lechner MG; Masood R; Sinha UK; Han J; Puri RK; Correa AJ; Epstein AL
Head Neck Oncol; 2010 Feb; 2():5. PubMed ID: 20175927
[TBL] [Abstract][Full Text] [Related]
37. The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease.
Kandil A; Bazarbashi S; Mourad WA
Cancer; 2001 Jun; 91(11):1957-63. PubMed ID: 11391573
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
[TBL] [Abstract][Full Text] [Related]
39. HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region.
Bussu F; Sali M; Gallus R; Petrone G; Autorino R; Santangelo R; Pandolfini M; Miccichè F; Delogu G; Almadori G; Galli J; Sanguinetti M; Rindi G; Tommasino M; Valentini V; Paludetti G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S979-84. PubMed ID: 26286196
[TBL] [Abstract][Full Text] [Related]
40. T-Lymphocyte Activation Is Correlated With the Presence of Anti-EBV in Patients With Laryngeal Squamous Cell Carcinoma.
Klatka J; Hymos A; Szkatuła-Łupina A; Grywalska E; Klatka B; Terpiłowski M; Stepulak A
In Vivo; 2019; 33(6):2007-2012. PubMed ID: 31662531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]